Koninklijke Philips Electronics is a global leader in health technology, focused on improving people's lives through meaningful innovation
The company develops a wide range of products and solutions, including medical devices, diagnostic imaging, patient monitoring systems, and consumer health products. Its commitment to enhancing healthcare and well-being extends into areas such as personal health, connected care, and sustainable development, aiming to deliver integrated solutions that empower both health professionals and patients. Philips combines advanced technologies with deep clinical and consumer insights to create solutions that drive better outcomes and improve the quality of care across various settings.
March 24, 2025Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes.As previously announced, the agenda includes:
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Ingeborg Initiatives are teaming up to provide all expectant parents in Arkansas with access to Philips Avent Pregnancy+ app with customized state-offered information and tools to increase access to care, improve health literacy and adopt healthy habits. State residents who download the Pregnancy+ app will automatically receive access to this premium, customized content.
March 12, 2025Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced it has been recognized by Clarivate as the top-ranked medical technology company in the Top 100 Global Innovators 2025, reinforcing its global reputation as a leading healthcare innovator. A consistent high-performer, Philips has been included in this major assessment of global innovators for 12 consecutive years. Roy Jakobs, CEO of Royal Philips said: "At Philips, we’ve been innovating for over 130 years to improve people’s lives. Innovation is our fundamental strength, the reason why customers choose us as their strategic partner and a key value driver for our company. Our portfolio of patient- and people-centric innovations in hardware, software, AI and services drives healthcare productivity and empowers people to look after their health and well-being – delivering better care for more people."In 2024, Philips invested approximately EUR 1.7 billion – or an industry leading >9% of sales – in research and development to help drive better care for more people. Philips is increasingly focusing its innovation efforts on the potential of data and AI, both in hospital settings and at home. As a leader in AI-related patent applications in healthcare, Philips dedicates around half of its R&D workforce to these fields. Examples of Philips’ AI-powered innovations that increase caregiver productivity and deliver better care for more people include:
Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced that Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has selected AWS as its preferred cloud provider to advance its business transformation and deliver secure and innovative healthcare informatics solutions globally. Philips’ cloud-first, AI-enabled approach is improving the company’s ability to deliver better care for more people, providing faster product development and reduced infrastructure costs.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, Amerigroup, CareSource Georgia, and Peach State Health Plan have partnered to provide remote monitoring solutions to expand access to quality healthcare for high-risk pregnancies in the state. In support of the Georgia Healthy Babies Act, the program will initially give pregnant and postpartum people with maternal hypertension and diabetes in 50 counties access to remote patient monitoring. Licensed clinical professionals will provide personalized health coaching to participants, monitoring them and intervening to avoid possible complications.
Philips Q4 earnings missed estimates as sales hit €5.04 billion. The company raised its 2023-2025 savings target to €2.5 billion and expects 2025 sales growth of 1%-3%.
February 19, 2025Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced proposed Supervisory Board appointments and reappointments, and a proposed Board of Management reappointment. Mr David Pyott (British/American, 1953) will retire from Philips’ Supervisory Board at the end of the Annual General Meeting of Shareholders 2025. Mr Pyott joined the Supervisory Board in 2015 and has served three consecutive terms. He has been Chair of the Quality & Regulatory Committee since May 2020.The Supervisory Board will propose to the Annual General Meeting of Shareholders 2025 the appointment of Mr Bob White (American, 1962) as a new member of the Supervisory Board. Following his appointment, Mr White will succeed Mr Pyott as Chair of the Quality & Regulatory Committee.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the company earned a spot on the Forbes “Canada’s Best Employers 2025” list for the second year in a row. The exclusive ranking is limited to 300 organizations in various industries countrywide, with Philips ranking second in the Healthcare Equipment & Services Category and moving up the list by more than 160 spots from last year.
To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast Florida Healthy Start Coalition (NEFHSC), Baptist Health and Philips Avent (NYSE: PHG, AEX: PHIA) have partnered to offer a one-year, no-cost subscription to the premium version of Philips’ Pregnancy+. Pregnancy+, the number one pregnancy app worldwide, will be available to women and their families in Baker, Clay and Duval counties.
